How a Bold Yes Became a Scientific Breakthrough

City of Hope, Monty Pal, Linda Malkas, AOH1996, Ana Olivia Healy

Dr. Linda Malkas shares the story behind AOH1996—how one bold “yes” led to a new cancer drug and a legacy built from love and science.

Jun 9^th • 47 mins listen

Navigating the Future of CDXs in Oncology

Rebecca Previs, Dawn McHugh, Labcorp, precision oncology, companion diagnostics, CDx, biomarker, precision medicine

CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.

Feb 18^th • 26 mins listen

Redefining Ovarian Cancer Care with Biomarkers

Labcorp, Rebecca Previs, Kyle Strickland, ovarian cancer, diagnosis, biomarker, HRD, RB1, tumor biology

Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.

Sep 7^th • 14 mins listen

The Quest to Cure: Exploring the Latest Frontiers in Autoimmune Disease Treatment

City of Hope, Enrique Montero, Monty Pal, autoimmune, CD6, T cell, type 1 diabetes, GVHD, CAR Tregs, regenerate

Dr. Monty Pal welcomes Dr. Enrique Montero, research professor within the Arthur Riggs Diabetes & Metabolism Research Institute, to discuss his global journey in immunology and the pioneering work underway at City of Hope. The episode dives into the significance of the CD6 molecule on T cells - how…

Dec 10^th • 39 mins listen

How to Accelerate Cancer Cures Through Collaboration with Kirk V. Shepard, MD

Kirk Shepard, Michael Pietrack, mentor, AI, digital

Join host Michael Pietrack on the PharmaVerse Podcast as he speaks with Dr. Kirk Shepard, Chief Medical Officer of PDS Biotechnology, co-founder of the Medical Affairs Professional Society (MAPS), and creator of the Oncology Voices Network (OVN).

Feb 2^nd • 24 mins listen